Perrigo (PRGO) Restructuring Costs (2013 - 2026)
Perrigo's (PRGO) quarterly Restructuring Costs came in at $75.1 million in Q1 2026, up 155.44% year-on-year from $29.4 million in Q1 2025, and up 477.69% on a QoQ basis from $13.0 million in Q4 2025.
Perrigo (PRGO) Restructuring Costs (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Restructuring Costs data on file, last reported at $75.1 million in Q1 2026.
- On a quarterly basis, Restructuring Costs rose 155.44% year-over-year to $75.1 million in Q1 2026; TTM through Mar 2026 was $117.6 million, a 23.66% increase from a year earlier, with the FY2025 full-year figure at $71.9 million, down 34.7% from the prior year.
- Restructuring Costs for Q1 2026 stood at $75.1 million, up from $13.0 million in the prior quarter.
- Over the last five years, Restructuring Costs for PRGO reached as high as $75.1 million in Q1 2026 and fell as low as $3.4 million in Q2 2023.
- Historically, Restructuring Costs has averaged $20.1 million across 5 years, with a median of $15.5 million in 2023.
- Across the five-year window, Restructuring Costs jumped 1810.0% in 2022 and tumbled 76.42% in 2025, its largest moves.
- Year by year, Restructuring Costs stood at $10.3 million in 2022, then jumped by 60.19% to $16.5 million in 2023, then dropped by 27.27% to $12.0 million in 2024, then increased by 8.33% to $13.0 million in 2025, then soared by 477.69% to $75.1 million in 2026.
- Per Business Quant data, the three most recent Restructuring Costs figures were $75.1 million in Q1 2026, $13.0 million in Q4 2025, and $20.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 75.10 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 27, 2025 | 20.80 Mn |
| Jun 28, 2025 | 8.70 Mn |
| Mar 29, 2025 | 29.40 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 28, 2024 | 16.80 Mn |
| Jun 29, 2024 | 36.90 Mn |
| Mar 30, 2024 | 44.30 Mn |
| Dec 31, 2023 | 16.50 Mn |
| Sep 30, 2023 | 15.50 Mn |
| Jul 1, 2023 | 6.70 Mn |
| Apr 1, 2023 | 3.40 Mn |
| Dec 31, 2022 | 10.30 Mn |
| Oct 1, 2022 | 19.10 Mn |
| Jul 2, 2022 | 9.50 Mn |
| Apr 2, 2022 | 3.60 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Oct 2, 2021 | 1.00 Mn |
| Jul 3, 2021 | 9.00 Mn |